Biotech StocksStock News Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that randomization of patients into the REDUCE-IT cardiovascular outcomes study has been completed with 8,175 individual patients randomized, … Corey Williams, August 31, 2016
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Proposed Public Offering of American Depositary Shares Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that it has commenced an underwritten public offering of its American Depositary pursuant to a shelf registration. All … Corey Williams, August 10, 2016
Biotech StocksInsightsMost Popular H.C. Wainwright Shines Light on Amarin Corporation plc (ADR) (AMRN) 2Q:16 Update In a research report issued Friday, H.C. Peter Murray, Editor, August 5, 2016
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and FDA Reaffirm Concurrence on REDUCE-IT Through Special Protocol Assessment Agreement Amendment Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that the U.S. Corey Williams, August 4, 2016
Biotech StocksMost PopularStock News Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Names Michael W. Kalb Chief Financial Officer Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that starting Michael W. Kalb has joined its senior management team as senior vice president and chief financial … Corey Williams, June 30, 2016
Biotech StocksStock News Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) to Present Vascepa(R) Data at American Diabetes Association’s 76th Scientific Sessions Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that new data related to Vascepa® (icosapent ethyl) will be presented at the upcoming American Diabetes Association(ADA) 76th … Corey Williams, June 6, 2016
Biotech StocksStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) Capsules Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that the U.S. Corey Williams, May 31, 2016
Biotech StocksMost PopularStock News Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces Poster Presentation At National Lipid Association Annual Meeting Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of a poster at the annual meeting of the National Lipid Association (NLA) further characterizing the … Corey Williams, May 20, 2016
Biotech StocksInsights H.C. Wainwright Reiterates Buy on Amarin Corporation plc (ADR) Following 1Q:16 Update In a research report issued this morning, H.C. Jason Cohen, May 6, 2016
Biotech StocksStock News Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Reports First Quarter 2016 Financial Results and Provides Update on Operations Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced financial results for … Corey Williams, May 5, 2016
